SLC5A2 and type 2 diabetes mellitus: The key objective of this study is to carry out a systematic review with a subsequent network meta-analysis of randomized controlled trials with the view of comparing the efficacy (HBA1c, survival benefit, and weight reduction) of different SGLT2 inhibitors in patients with type II diabetes.